Stromberg B E, Averbeck G A, Anderson J F, Woodward B W, Cunningham J, Brake A, Skogerboe T
Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul 55108, USA.
Vet Parasitol. 1999 Nov;87(1):45-50. doi: 10.1016/s0304-4017(99)00163-6.
The persistent efficacy of the injectable and topical formulations of doramectin was compared against experimental challenges with infective larvae of Dictyocaulus viviparus in two separate studies. Four groups of 10 randomly-assigned calves, negative for lungworm larvae by the Baermann technique, were used in each study. Calves were treated subcutaneously in the midline of the neck or poured down the midline of the back with saline (1 ml/50 kg. injection: 1 ml/10 kg. pour-on) on Day 0 or doramectin (200 microg/kg = 1 ml/50 kg. injection: 500 microg/kg = 1 ml/10 kg. pour-on) on Day 0, 7, or 14. Two additional calves from the same pool of animals were randomly assigned as larval-viability monitors and received no treatment. Calves were inoculated daily with a gavage of approximately 100 larvae of D. viviparus from days 35 to 49 for the injectable study and days 28 to 42 for the pour-on study. The two larval viability monitor calves received approximately 3000 infective larvae in the same manner on Day 49 or 42 for the injectable and pour-on studies, respectively. Equal numbers of calves from each treatment group as well as the larval viability monitor calves were necropsied on days 14 and 15 after the last lungworm inoculation to enumerate the worm burden. The worms recovered were quantified and identified. For each study, geometric mean worm recoveries for each treatment group were back transformed from the natural log-transformed data (worm count +1) and were used to estimate percentage reduction. Doramectin injectable solution was 100.0% efficacious against lungworms for up to 49 days and the pour-on formulation was 100.0%, 93.1% and 81.5% effective in reducing lungworm infection resulting from challenge infection for up to 28, 35, and 42 days post-treatment, respectively.
在两项独立研究中,比较了多拉菌素注射剂和外用制剂对胎生网尾线虫感染性幼虫实验性攻击的持续效力。每项研究使用四组,每组10头通过贝尔曼技术检测肺线虫幼虫呈阴性的随机分组小牛。在第0天,小牛颈部中线皮下注射或背部中线浇淋生理盐水(1毫升/50千克,注射;1毫升/10千克,浇淋),或在第0天、第7天或第14天注射多拉菌素(200微克/千克 = 1毫升/50千克,注射;500微克/千克 = 1毫升/10千克,浇淋)。从同一批动物中另外随机选取两头小牛作为幼虫活力监测器,不进行处理。在注射剂研究中,从第35天至49天,以及在外用制剂研究中,从第28天至42天,小牛每天经口投喂约100条胎生网尾线虫幼虫。在注射剂和外用制剂研究中,这两头幼虫活力监测器小牛分别在第49天或第42天以相同方式接受约3000条感染性幼虫。在最后一次肺线虫接种后第14天和第15天,对每个治疗组相同数量的小牛以及幼虫活力监测器小牛进行尸检,以统计虫负荷。对回收的蠕虫进行定量和鉴定。对于每项研究,每个治疗组的几何平均蠕虫回收率从自然对数转换数据(蠕虫计数 +1)进行反转换,并用于估计减少百分比。多拉菌素注射剂溶液对肺线虫的效力在长达49天内为100.0%,外用制剂在治疗后长达28天、35天和42天分别对攻击感染导致的肺线虫感染减少有效率为100.0%、93.1%和81.5%。